Estrogen causes rapid endothelial nitric oxide (NO) production because of the activation of plasma membrane-associated estrogen receptors (ER) coupled to endothelial NO synthase (eNOS). In the present study, we determined the role of G proteins in eNOS activation by estrogen. Estradiol-17 (E 2 , 10 ؊8 M) and acetylcholine (10 ؊5 M) caused comparable increases in NOS activity (15 min) in intact endothelial cells that were fully blocked by pertussis toxin (Ptox). In addition, exogenous guanosine 5-O-(2-thiodiphosphate) inhibited E 2 -mediated eNOS stimulation in isolated endothelial plasma membranes, and Ptox prevented enzyme activation by E 2 in COS-7 cells expressing ER␣ and eNOS. Coimmunoprecipitation studies of plasma membranes from COS-7 cells transfected with ER␣ and specific G␣ proteins demonstrated E 2 -stimulated interaction between ER␣ and G␣ i but not between ER␣ and either G␣ q or G␣ s ; the observed ER␣-G␣ i interaction was blocked by the ER antagonist ICI 182,780 and by Ptox. E 2 -stimulated ER␣-G␣ i interaction was also demonstrable in endothelial cell plasma membranes. Cotransfection of G␣ i into COS-7 cells expressing ER␣ and eNOS yielded a 3-fold increase in E 2 -mediated eNOS stimulation, whereas cotransfection with a protein regulator of G protein signaling, RGS4, inhibited the E 2 response. These findings indicate that eNOS stimulation by E 2 requires plasma membrane ER␣ coupling to G␣ i and that activated G␣ i mediates the requisite downstream signaling events. Thus, novel G protein coupling enables a subpopulation of ER␣ to initiate signal transduction at the cell surface. Similar mechanisms may underly the nongenomic actions of other steroid hormones.The hormone estrogen classically exerts its effects by modifying gene expression through the action of estrogen receptors that serve as transcription factors (1). There are also important nongenomic actions of estrogen in a variety of tissues including bone, mammary gland, pituitary gland, neuron, ovary, and vasculature (2-5). We and others have previously shown that estrogen acutely stimulates the endothelial isoform of nitric oxide synthase (eNOS) 1 by mechanisms that are nongenomic yet mediated by estrogen receptor ␣ (ER␣) (6 -8).Recent studies demonstrate that there is a subpopulation of ER␣ localized to the endothelial cell plasma membrane in caveolae, where it functions in a signaling module with eNOS (9). Involvement of the tyrosine kinase-MAP kinase signaling pathway has been implicated in the mechanism of ER-mediated eNOS activation (8), and very recent work supports a role for the recruitment of the PI3-kinase-Akt pathway that may entail direct interaction between ER␣ and the p85 subunit of PI3-kinase (10, 11). However, the mechanisms by which plasma membrane ER␣ initiate signaling events remain unresolved (12). The best-described agonists for eNOS, acetylcholine and bradykinin, activate specific plasma membrane-associated G protein-coupled receptors (GPCR) (13,14). G proteins are heterotrimers of ␣, , and ␥ subunits (G␣␥), which...